| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Head Of R&D | Head Of Research And Developme | Head Of Research And Developme +1 more
1 company
Blackman Samuel C. is a Head Of R&D at Day One Biopharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $22.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 30,000 | $13.31 | $399,339.00 | -2.8% | -39.0% | -35.6% | |
| Nov 18, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sale+OE | 2,206 | $13.21 | $29,141.70 | -0.2% | -8.3% | -34.1% | |
| Nov 11, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 28,255 | $16.15 | $456,222.99 | -1.3% | -25.2% | -34.7% | |
| Nov 7, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 11,245 | $16.03 | $180,286.59 | -1.0% | -22.5% | -38.3% | |
| Oct 31, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 500 | $16.02 | $8,010.00 | - | -11.6% | -49.5% | |
| Sep 10, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 30,000 | $14.22 | $426,675.00 | -2.7% | -6.1% | -49.4% | |
| Aug 16, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sale+OE | 2,232 | $14.00 | $31,245.99 | -0.2% | +2.9% | -51.5% | |
| Jul 16, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 20,000 | $16.01 | $320,226.00 | -1.8% | -10.7% | -58.7% | |
| Jun 10, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sell | 30,000 | $12.62 | $378,588.00 | -2.6% | +13.7% | -44.1% | |
| May 16, 2024 | DAWN Day One Biopharmaceuticals, Inc. | Head Of R&D | Sale+OE | 2,267 | $16.08 | $36,450.41 | -0.2% | -16.3% | -61.0% |